NASD · Industrials · Integrated Freight & Logistics · USA
CryoPort Inc is a small cap company (market value between $300 million and $2 billion) in the Integrated Freight & Logistics industry.
CryoPort provides integrated, temperature-controlled supply chain solutions for life sciences, particularly cell and gene therapy markets. The company delivers logistics, biostorage, cryopreservation services, and cryogenic systems manufacturing to biopharmaceutical companies, research institutions, and government agencies worldwide. Its services support safe handling and delivery of temperature-sensitive biological materials from preclinical development through commercial distribution.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the CryoPort Inc stock.
Overvalued: intrinsic value $5.32 per share, market price $19.74, margin of safety -271.3% (as of 2026-11-17).
A 0.8x revenue multiple, discounted for its losses, values the shares at $5.32; the price of $19.74 is 271% above that value.
17 more funds hold it; the full list is part of the paid plan.
All 32 Integrated Freight & Logistics stocks
8 more in this industry show a wider margin of safety.
CYRX is overvalued (as of the 2026-11-17 close). A 0.8x revenue multiple, discounted for its losses, values the shares at $5.32; the price of $19.74 is 271% above that value.
$5.32 per share (as of the 2026-11-17 close), against a market price of $19.74. That is a margin of safety of -271.3%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.